Skip to main content
Log in

Myelodysplastic syndrome associated with relapsing polychondritis: Unusual transformation from refractory anemia to chronic myelomonocytic leukemia

  • Case Report
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

The authors report an unusual case of myelodysplastic syndrome (MDS) associated with relapsing polychondritis (RP), which developed at almost the same time as MDS. The initial diagnosis was MDS, refractory anemia (RA) subtype, according to the FAB classification [3]. Symptoms of RP were apparently controlled by oral administration of prednisolone (PSL), although MDS was not. Within 1 month after the diagnosis, monocytosis and thrombocytopenia without excess of blasts became prominent and transformation from RA to chronic myelomonocytic leukemia (CMML) was recognized. Combination chemotherapy including daunorubicin (DNR) and cytosine arabinoside (ara-c) did not subdue the progressive monocytosis and thrombocytopenia. Finally, the patient died of pulmonary hemorrhage 3 months after the onset of the disease. The prognosis of MDS may be poorly influenced by association with RP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Anstey A, Mayou S, Morgan K, et al. (1991) Relapsing polychondritis: autoimmunity to type-II collagen and treatment with cyclosporin A. Br J Dermatol 125: 588–591

    Google Scholar 

  2. Arlet P, Pris J, Sallerin E, et al. (1989) Polychondrite chronique atrophiante. Presse Med 18: 157–160

    Google Scholar 

  3. Bennett JM, Catovsky D, Daniel MT, et al. (1982) Proposais for the classification of the myelodysplastic syndromes. Br J Hematol 51: 189–199

    Google Scholar 

  4. Besien KV, Tricot G, Hoffman R (1992) Relapsing polychondritis: a paraneoplastic syndrome associated with myelodysplastic syndromes. Am J Hematol 40: 47–50

    Google Scholar 

  5. Bynoe AG, Scott CS, Ford P, et al. (1983) Decreased T-helper cells in the myelodysplastic syndromes. Br J Hematol 54: 97–102

    Google Scholar 

  6. Ebringer R, Rook G, Swana GT, et al. (1981) Autoantibodies to cartilage and type-II collagen in relapsing polychondritis and other rheumatic diseases. Ann Rheum Dis 40: 473–479

    Google Scholar 

  7. Economopoulos T, Economidou J, Giannopoulos G, et al. (1985) Immune abnormalities in myelodysplastic syndromes. J Clin Pathol 38: 908–911

    Google Scholar 

  8. Foidart JM, Abe S, Martin GR, et al. (1978) Antibodies to type-II collagen in relapsing polychondritis. N Engl J Med 299: 1203–1207

    Google Scholar 

  9. Foucar K, Langdon RM, Armitage JO, et al. (1985) Myelodysplastic syndrome. A clinical and pathologic analysis of 109 cases. Cancer 56: 553–561

    Google Scholar 

  10. Giroux L, Paquin F, Guerard-Desjardins MJ, et al. (1983) Relapsing polychondritis: an autoimmune disease. Semin Arthritis Rheum 13: 182–187

    Google Scholar 

  11. Kerndrup G, Meyer K, Ellegaard J, et al. (1984) Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome. Leukemia Res 8: 239–247

    Google Scholar 

  12. McAdam LP, O'Hanlan MA, Bluestone R, et al. (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine 55: 193–215

    Google Scholar 

  13. McCune JW, Scheller AL, Dynesius-Trentham RA, et al. (1982) Type-II collagen-induced auricular arthritis. Arthritis Rheum 25: 266–273

    Google Scholar 

  14. Michet CJ, McKenna CH, Luthra HS, et al. (1986) Relapsing polychondritis: survival and predictive role of early disease manifestations. Ann Intern Med 104: 74–78

    Google Scholar 

  15. Mufti GJ, Figes A, Hamblin TJ, et al. (1986) Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies. Br J Haematol 63: 143–147

    Google Scholar 

  16. Nashef L, Doherty M, Dieppe P (1986) Relapsing polychondritis: a primary or secondary autoimmune disease? Br J Rheum 25: 85–86

    Google Scholar 

  17. Omine M, Yamaguchi H (1989) Clinical aspects of the myelodysplastic syndrome (MDS) with special reference to refractory anemia with excess of blasts (RAEB). Acta Haematol Jpn 52: 800–810

    Google Scholar 

  18. Sanz GF, Sanz MA (1992) Prognostic factors in myelodysplastic syndromes. Leuk Res 16: 77–86

    Google Scholar 

  19. Vallespi M, Torrabadella M, Julia A, et al. (1985) Myelodysplastic syndromes: a study of 101 cases according to the FAB classification. Br J Haematol 61: 83–92

    Google Scholar 

  20. Weide M van der, Sizoo W, Nauta JJP, et al. (1988) Myelodysplastic syndromes: analysis of clinical and prognostic features in 96 patients. Eur J Haematol 41: 115–122

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shirota, T., Hayashi, O., Uchida, H. et al. Myelodysplastic syndrome associated with relapsing polychondritis: Unusual transformation from refractory anemia to chronic myelomonocytic leukemia. Ann Hematol 67, 45–47 (1993). https://doi.org/10.1007/BF01709666

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01709666

Key words

Navigation